Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges.

recombinant proteins were evaluated as smallpox and monkeypox vaccines because of their perceived safety compared with live vaccinia virus. Previously, we showed that three or more injections of Ribi adjuvant-type with a triple combination of the outer membrane of intracellular proteins (L1 proteins) and extracellular (A33 and B5 protein) form of vaccinia virus protected mice against lethal intranasal challenge with vaccinia virus. 

Here, we compare some adjuvants and Hapten Conjugates Proteins  found that QS-21, and to a lesser extent alum + oligodeoxynucleotides CpG accelerated and improved neutralizing antibody responses against a mixture of L1 and A33 protein, provided the highest ratio of IgG2a response of isotype IgG1, and mice are protected against disease and death after only two immunizations three weeks.

 In addition, the monkeys were immunized with recombinant vaccinia virus proteins and QS-21 developed neutralizing antibodies against monkeypox virus and to reduce the viral load, skin lesions, and morbidity compared to the non-immunized group following monkeypox virus challenge.

Validation of ELISA for the determination of antibodies induced in monkeys against Epi-hNE4, recombinant protein inhibitor of human neutrophil elastase.

engineered protein inhibitor of human neutrophil elastase, Epi-hNE4, is being developed for the treatment of cystic fibrosis. Like many recombinant proteins, Epi-hNE4 may lead to antibodies in pre-clinical species and in humans. The purpose of this report is to validate the ELISA to assess immunogenicity in monkeys. 

We have designed and optimized classical ELISA where Epi-hNE4 coated directly on the microtitre plate and the antibody was https://gentaur.be/ detected using a secondary antibody labeled with peroxidase. We report the implementation of the recommendations proposed recently for the validation of immunogenicity assessment.

 Cut-off point is determined by statistical analysis of the negative samples. Linearity, reproducibility, stability and specificity were estimated using quality control samples were obtained from a pool of positive samples. This method is applied for the monkeys given the Epi-hNE4 inhalation